Welcome to Anhui Poly Pharm. Co., Ltd.
language
中文 EN
Molecular formulaC23H42GdN5O13
CAS No.92943-93-6
StatusA
SepcIn-house
NotesDMF
Structural formula
Product advantages
With gadolinium oxide serving as the starting materials, the product boasts favorable price, easy availability, and good stability;
The product boasts better quality than RLD: Individual impurities are all less than 0.05%, inorganic salts are strictly controlled, chloride ions are less than 100ppm, and lithium are less than 18ppm.
The injection excipient DOTA and the API meglumine gadoterate are available (the excipient DOTA is in line with USP standards).
The product is in line with the specifications of ChP, USP, etc.
The product has passed China's registration inspection, GMP conformity inspection, and US FDA on-site inspection.
There are high-degree automated and dedicated production line for stable supply with well-ensured quality;
The annual production capacity is over 10 tons.
Related product information
  • PDF file

    钆特酸葡胺 中国原料药登记A.pdf

    Size:226.81KB

  • PDF file

    2-Gadoterate Meglumine DMF 037072-AC letter.pdf

    Size:165.54KB